Reduction of human blood O2 affinity using dihydroxyacetone, phosphate, and pyruvate

H. H. Kerr; G. A. Pantely; J. Metcalfe; J. E. Welch

Reduction of human blood O₂ affinity using dihydroxyacetone, phosphate, and pyruvate

H. H. Kerr, G. A. Pantely, J. Metcalfe, J. E. Welch

Research output: Contribution to journal › Article › peer-review

Abstract

Human blood oxygen affinity (BOA) was measured after blood from 6 normal donors was incubated with 4 concentrations of dihydroxyacetone (0.022, 0.044, 0.088, and 0.175 M) plus equimolar disodium phosphate and pyruvate (sodium salt) (0.013, 0.025, 0.05 and 0.1 M) in solutions labeled DDP x 1, DDP x 2, DDP x 4, and DDP x 8, respectively. Blood P₅₀ rose (BOA was reduced) from a control value of 26.0 ± 0.4 Torr (mean ± SD) to 29.4 ± 0.6, 30.6 ± 0.4, 31.9 ± 0.15, and 33.3 ± 1.4 Torr after 2 hr of incubation at 37° C with solutions DDP x 1, DDP x 2, DDP x 4, and DDP x 8, respectively. P₅₀ changes at 2 hr were 75% complete within 30 min. During these incubations, erythrocyte 2,3-diphosphoglycerate (2,3-DPG) concentration rose from 0.76 ± 0.09 mol/mol Hb (control) to 1.09 ± 0.17, 1.14 ± 0.10, 1.33 ± 0.15, and 1.45 ± 0.25 mol/mol Hb with increasing solution concentration. BOA is decreased by an increase in erythrocyte 2,3-DPG. Reduced BOA may improve oxygen delivery to ischemic tissues.

Original language	English (US)
Pages (from-to)	478-481
Number of pages	4
Journal	Journal of Applied Physiology Respiratory Environmental and Exercise Physiology
Volume	47
Issue number	3
State	Published - Dec 1 1979

ASJC Scopus subject areas

Physiology
Endocrinology

Fingerprint Dive into the research topics of 'Reduction of human blood O<sub>2</sub> affinity using dihydroxyacetone, phosphate, and pyruvate'. Together they form a unique fingerprint.

Cite this

@article{2e1c53f4736f41bc9ab4923841597a95,

title = "Reduction of human blood O2 affinity using dihydroxyacetone, phosphate, and pyruvate",

abstract = "Human blood oxygen affinity (BOA) was measured after blood from 6 normal donors was incubated with 4 concentrations of dihydroxyacetone (0.022, 0.044, 0.088, and 0.175 M) plus equimolar disodium phosphate and pyruvate (sodium salt) (0.013, 0.025, 0.05 and 0.1 M) in solutions labeled DDP x 1, DDP x 2, DDP x 4, and DDP x 8, respectively. Blood P50 rose (BOA was reduced) from a control value of 26.0 ± 0.4 Torr (mean ± SD) to 29.4 ± 0.6, 30.6 ± 0.4, 31.9 ± 0.15, and 33.3 ± 1.4 Torr after 2 hr of incubation at 37° C with solutions DDP x 1, DDP x 2, DDP x 4, and DDP x 8, respectively. P50 changes at 2 hr were 75% complete within 30 min. During these incubations, erythrocyte 2,3-diphosphoglycerate (2,3-DPG) concentration rose from 0.76 ± 0.09 mol/mol Hb (control) to 1.09 ± 0.17, 1.14 ± 0.10, 1.33 ± 0.15, and 1.45 ± 0.25 mol/mol Hb with increasing solution concentration. BOA is decreased by an increase in erythrocyte 2,3-DPG. Reduced BOA may improve oxygen delivery to ischemic tissues.",

author = "Kerr, {H. H.} and Pantely, {G. A.} and J. Metcalfe and Welch, {J. E.}",

year = "1979",

month = dec,

day = "1",

language = "English (US)",

volume = "47",

pages = "478--481",

journal = "Journal of Applied Physiology",

issn = "8750-7587",

publisher = "American Physiological Society",

number = "3",

}

TY - JOUR

T1 - Reduction of human blood O2 affinity using dihydroxyacetone, phosphate, and pyruvate

AU - Kerr, H. H.

AU - Pantely, G. A.

AU - Metcalfe, J.

AU - Welch, J. E.

PY - 1979/12/1

Y1 - 1979/12/1

N2 - Human blood oxygen affinity (BOA) was measured after blood from 6 normal donors was incubated with 4 concentrations of dihydroxyacetone (0.022, 0.044, 0.088, and 0.175 M) plus equimolar disodium phosphate and pyruvate (sodium salt) (0.013, 0.025, 0.05 and 0.1 M) in solutions labeled DDP x 1, DDP x 2, DDP x 4, and DDP x 8, respectively. Blood P50 rose (BOA was reduced) from a control value of 26.0 ± 0.4 Torr (mean ± SD) to 29.4 ± 0.6, 30.6 ± 0.4, 31.9 ± 0.15, and 33.3 ± 1.4 Torr after 2 hr of incubation at 37° C with solutions DDP x 1, DDP x 2, DDP x 4, and DDP x 8, respectively. P50 changes at 2 hr were 75% complete within 30 min. During these incubations, erythrocyte 2,3-diphosphoglycerate (2,3-DPG) concentration rose from 0.76 ± 0.09 mol/mol Hb (control) to 1.09 ± 0.17, 1.14 ± 0.10, 1.33 ± 0.15, and 1.45 ± 0.25 mol/mol Hb with increasing solution concentration. BOA is decreased by an increase in erythrocyte 2,3-DPG. Reduced BOA may improve oxygen delivery to ischemic tissues.

AB - Human blood oxygen affinity (BOA) was measured after blood from 6 normal donors was incubated with 4 concentrations of dihydroxyacetone (0.022, 0.044, 0.088, and 0.175 M) plus equimolar disodium phosphate and pyruvate (sodium salt) (0.013, 0.025, 0.05 and 0.1 M) in solutions labeled DDP x 1, DDP x 2, DDP x 4, and DDP x 8, respectively. Blood P50 rose (BOA was reduced) from a control value of 26.0 ± 0.4 Torr (mean ± SD) to 29.4 ± 0.6, 30.6 ± 0.4, 31.9 ± 0.15, and 33.3 ± 1.4 Torr after 2 hr of incubation at 37° C with solutions DDP x 1, DDP x 2, DDP x 4, and DDP x 8, respectively. P50 changes at 2 hr were 75% complete within 30 min. During these incubations, erythrocyte 2,3-diphosphoglycerate (2,3-DPG) concentration rose from 0.76 ± 0.09 mol/mol Hb (control) to 1.09 ± 0.17, 1.14 ± 0.10, 1.33 ± 0.15, and 1.45 ± 0.25 mol/mol Hb with increasing solution concentration. BOA is decreased by an increase in erythrocyte 2,3-DPG. Reduced BOA may improve oxygen delivery to ischemic tissues.

UR - http://www.scopus.com/inward/record.url?scp=0018730247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018730247&partnerID=8YFLogxK

M3 - Article

C2 - 118143

AN - SCOPUS:0018730247

VL - 47

SP - 478

EP - 481

JO - Journal of Applied Physiology

JF - Journal of Applied Physiology

SN - 8750-7587

IS - 3

ER -

Reduction of human blood O2 affinity using dihydroxyacetone, phosphate, and pyruvate

Abstract

ASJC Scopus subject areas

Other files and links

Cite this

Reduction of human blood O₂ affinity using dihydroxyacetone, phosphate, and pyruvate